not tagged
santen
['breast', 'lumina', 'bcsm']
lumina: supports consideration of omission of adjuvant radiation in women age 55+ with luminal a invasive ductal breast cancer, pt1n0, grade 1-2, er &gt;1%, pr &gt;20%, her2-, ki-67 &lt;13.25, endocrine therapy x 5y. median follow-up 5 years. timothy whelan of #asco22 #bcsm 
Medical oncologist @Intermountain, Director of Breast Oncology. Clinical research, quality improvement, cardio-oncology, provider wellness. All tweets my own.